Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP583815.RAeK8mjjiB4binhSyLBqyfJCd1JCsRgxCbHmLucBmv-yA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP583815.RAeK8mjjiB4binhSyLBqyfJCd1JCsRgxCbHmLucBmv-yA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP583815.RAeK8mjjiB4binhSyLBqyfJCd1JCsRgxCbHmLucBmv-yA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP583815.RAeK8mjjiB4binhSyLBqyfJCd1JCsRgxCbHmLucBmv-yA130_provenance.
- NP583815.RAeK8mjjiB4binhSyLBqyfJCd1JCsRgxCbHmLucBmv-yA130_assertion description "[Amplification of the CBFbeta/MYH11 fusion transcript by a qualitative reverse transcription-polymerase chain reaction (RT-PCR) has been used to detect minimal residual disease (MRD) and assess the risk for disease relapse in inv(16)(p13q22) acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP583815.RAeK8mjjiB4binhSyLBqyfJCd1JCsRgxCbHmLucBmv-yA130_provenance.
- NP583815.RAeK8mjjiB4binhSyLBqyfJCd1JCsRgxCbHmLucBmv-yA130_assertion evidence source_evidence_literature NP583815.RAeK8mjjiB4binhSyLBqyfJCd1JCsRgxCbHmLucBmv-yA130_provenance.
- NP583815.RAeK8mjjiB4binhSyLBqyfJCd1JCsRgxCbHmLucBmv-yA130_assertion SIO_000772 11455976 NP583815.RAeK8mjjiB4binhSyLBqyfJCd1JCsRgxCbHmLucBmv-yA130_provenance.
- NP583815.RAeK8mjjiB4binhSyLBqyfJCd1JCsRgxCbHmLucBmv-yA130_assertion wasDerivedFrom befree-20150227 NP583815.RAeK8mjjiB4binhSyLBqyfJCd1JCsRgxCbHmLucBmv-yA130_provenance.
- NP583815.RAeK8mjjiB4binhSyLBqyfJCd1JCsRgxCbHmLucBmv-yA130_assertion wasGeneratedBy ECO_0000203 NP583815.RAeK8mjjiB4binhSyLBqyfJCd1JCsRgxCbHmLucBmv-yA130_provenance.
- befree-20150227 importedOn "2015-02-27" NP583815.RAeK8mjjiB4binhSyLBqyfJCd1JCsRgxCbHmLucBmv-yA130_provenance.